A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Apyx Medical Corp stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 86,609 shares of APYX stock, worth $106,529. This represents 0.0% of its overall portfolio holdings.

Number of Shares
86,609
Previous 84,523 2.47%
Holding current value
$106,529
Previous $113,000 5.31%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$1.01 - $1.46 $2,106 - $3,045
2,086 Added 2.47%
86,609 $107,000
Q2 2024

Jul 19, 2024

SELL
$1.26 - $1.66 $252 - $332
-200 Reduced 0.24%
84,523 $113,000
Q1 2024

Apr 22, 2024

SELL
$1.25 - $2.71 $654,881 - $1.42 Million
-523,905 Reduced 86.08%
84,723 $115,000
Q4 2023

Jan 16, 2024

BUY
$1.49 - $3.25 $279,151 - $608,887
187,350 Added 44.47%
608,628 $1.59 Million
Q3 2023

Oct 24, 2023

BUY
$3.07 - $6.2 $3,377 - $6,820
1,100 Added 0.26%
421,278 $1.35 Million
Q2 2023

Jul 25, 2023

BUY
$2.75 - $7.59 $75,215 - $207,594
27,351 Added 6.96%
420,178 $2.11 Million
Q1 2023

Apr 14, 2023

BUY
$2.45 - $3.59 $83,520 - $122,383
34,090 Added 9.5%
392,827 $1.13 Million
Q4 2022

Feb 08, 2023

SELL
$1.4 - $5.02 $70,522 - $252,872
-50,373 Reduced 12.31%
358,737 $839,000
Q3 2022

Oct 25, 2022

BUY
$4.49 - $10.83 $150,379 - $362,718
33,492 Added 8.92%
409,110 $1.84 Million
Q2 2022

Aug 12, 2022

BUY
$3.11 - $7.5 $227,067 - $547,590
73,012 Added 24.13%
375,618 $2.2 Million
Q1 2022

May 11, 2022

BUY
$5.87 - $13.13 $36,100 - $80,749
6,150 Added 2.07%
302,606 $1.98 Million
Q4 2021

Feb 08, 2022

BUY
$12.15 - $17.4 $109,155 - $156,321
8,984 Added 3.13%
296,456 $3.8 Million
Q3 2021

Nov 02, 2021

BUY
$8.79 - $13.96 $62,136 - $98,683
7,069 Added 2.52%
287,472 $3.98 Million
Q2 2021

Aug 11, 2021

BUY
$9.02 - $10.83 $46,768 - $56,153
5,185 Added 1.88%
280,403 $2.89 Million
Q1 2021

May 14, 2021

BUY
$6.91 - $11.81 $73,681 - $125,930
10,663 Added 4.03%
275,218 $2.66 Million
Q4 2020

Feb 12, 2021

BUY
$4.85 - $8.19 $35,138 - $59,336
7,245 Added 2.82%
264,555 $1.91 Million
Q3 2020

Nov 04, 2020

SELL
$4.38 - $5.47 $75,616 - $94,434
-17,264 Reduced 6.29%
257,310 $1.21 Million
Q2 2020

Jul 17, 2020

BUY
$2.87 - $5.83 $45,920 - $93,280
16,000 Added 6.19%
274,574 $1.52 Million
Q1 2020

Apr 21, 2020

BUY
$3.24 - $8.51 $32,724 - $85,951
10,100 Added 4.06%
258,574 $928,000
Q4 2019

Feb 12, 2020

SELL
$6.29 - $8.46 $64,629 - $86,926
-10,275 Reduced 3.97%
248,474 $2.1 Million
Q3 2019

Nov 07, 2019

BUY
$6.3 - $7.9 $83,878 - $105,180
13,314 Added 5.42%
258,749 $1.75 Million
Q2 2019

Aug 06, 2019

BUY
$3.64 - $6.95 $66,979 - $127,886
18,401 Added 8.1%
245,435 $1.65 Million
Q1 2019

May 06, 2019

BUY
$6.31 - $8.75 $1.43 Million - $1.99 Million
227,034 New
227,034 $1.43 Million

Others Institutions Holding APYX

About Apyx Medical Corp


  • Ticker APYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,573,000
  • Market Cap $42.5M
  • Description
  • Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ab...
More about APYX
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.